Regional Agency Celebrates Five Years of Financing North Holland Innovation

2026-11-06 community

Haarlem, Friday, 6 November 2026.
Marking five years of operations, ROM InWest has expanded beyond early-stage funding to help tackle a vital €100 million capital gap for regional biotech and sustainable technology ventures.

Five Years of Catalyzing Regional Capital

Since launching approximately five years ago, ROM InWest has transitioned from a regional newcomer into a core investor and network builder across the North Holland innovation landscape [1]. Funded and supported by the Dutch national government, the province of North Holland, and local municipalities, the development agency deploys dedicated business development and investment teams to provide essential capital alongside strategic guidance to early-stage ventures [1]. Operating alongside regional development agencies such as NOM, InnovationQuarter, and BOM across the Netherlands [4], ROM InWest focuses on de-risking high-potential commercial concepts to ensure regional businesses generate both societal and economic returns [1][4].

Diverse Deployments Across Sustainable Tech and Defense

The impact of this regional deployment model is visible across diverse commercial sectors ranging from smart agriculture to defense innovation [1]. In Amsterdam, portfolio company Agurotech has engineered agricultural sensor hardware and software solutions that now support hundreds of clients spanning more than twenty countries [1]. In the circular economy domain, Drystack developed a demountable, reusable facade construction system that enables bricks to be assembled completely without mortar [1]. Furthermore, regional security infrastructure has gained traction through initiatives like MINDBase Amsterdam, established to bridge commercial tech ventures with the Ministry of Defense, and P-X Systems, which marked the first North Holland firm to secure financing from the SecFund for dual-use technology [1].

Bridging the €100 Million Life Sciences Gap

Addressing early-stage market failures has emerged as a central pillar of ROM InWest’s strategic roadmap, particularly within high-barrier sectors like biotechnology and medical technology [1][2]. In collaboration with the Amsterdam Economic Board and ecosystem partners under the ‘De Slapende Reus’ initiative, regional research highlighted an estimated €100,000,000 funding deficit required to scale burgeoning biotech firms [1]. The broader North Holland and Amsterdam metropolitan landscape encompasses approximately 300 Life Science & Health (LSH) enterprises, drawing technical strength from academic hospitals, knowledge institutes, AI assets, and the NRG PALLAS nuclear facility in Petten [2]. To fuel systemic expansion, public and institutional stakeholders introduced the national MedTech 2035 agenda in late October 2026, backed by more than €300,000,000 from the Dutch cabinet, Invest-NL, pension funds, and Philips [2].

Connecting Capital and Scaling Accelerators

Facilitating direct investor engagement, ROM InWest and the Amsterdam Economic Board co-moderated the fourth annual LSH Capital Match on 5 November 2026 at the Matrix Innovation Centers deep-tech hub in Amsterdam [2]. Sponsored by Health Holland, the oversubscribed event gathered 75 startups and 34 institutional and angel investors, underscoring persistent demand for early-stage capital amidst rigorous clinical validation timelines [2]. This private matchmaking operates in tandem with targeted acceleration mechanisms such as the provincial GO!-NH program, operated jointly by the Province of North Holland, ROM InWest, and Ontwikkelingsbedrijf Noord-Holland Noord [3]. On 27 October 2026, GO!-NH launched its 2026–2027 cohort featuring 20 innovative firms—comprising 12 enterprises in the Market Readiness Program and 8 ventures in the Scaling Readiness Program—tackling areas from seaweed food packaging and flexible rainwater storage to closed-loop wool fertilizers [3].

Bronnen

regional investment innovation ecosystem